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Abstract
Background: To assess the maternal characteristics and nutritional status according to body mass index (BMI) at 6–
14 weeks of gestation and to examine the relationship between maternal nutritional status in early pregnancy and
its impact on neonatal birth weight.
Methods: The investigation was conducted from April 2011 to June 2012 in Dhaka, Bangladesh. A total of 498
primigravida pregnant women participated in the study; women with known diabetes or previous gestational
diabetes (GDM) were excluded. Maternal demographic details, pregnancy history and anthropometric measurements
were obtained from the mother at the recruitment (6–14 weeks), 2nd visit between 24 and 28 week of gestation and
3rd visit at delivery. Cord venous blood samples of newborns (n = 138) were collected immediately after delivery for
blood glucose, insulin, lipid profile, leptin and micronutrients including serum folate, ferritin, homocysteine, vitamin D,
and vitamin B12.
Results: The prevalence at 6–14 weeks of pregnancy of anemia (Hb, < 11 g/dl), vitamin D deficiency (< 30 nmol/l),
vitamin B12 deficiency (< 200 pg/ml), high homocysteine level (> 15 μmol/l), folate deficiency (< 3 ng/ml) and iron
deficiency (ferritin < 13 ng/ml) were 19.5, 46.4, 15.1, 1.2, 0.4, and 12.7% respectively. GDM was found in 18.4% women.
The prevalence of GDM was higher in overweight women (28.1%) than underweight (16.7%) and normal
weight women (16.0%: p < 0.05). The incidence of low birth weight (LBW) and preterm delivery were 11.6
and 5.8% respectively and was not related to maternal BMI at 6–14 weeks of pregnancy. Maternal height was
positively (p = 0.02), and homocysteine was negatively associated with neonatal birth weight (p = 0.02). In
addition, the newborn’s cord serum folate was positively (p = 0.03) and cord triglyceride was negatively (p = 0.03)
associated with neonatal birth weight.
Conclusion: Multiple maternal micronutrient deficiencies were present in early pregnancy. Maternal BMI in early
pregnancy was not related to preterm deliveries or LBW. LBW was associated with lower folate, elevated cord
triglyceride concentrations of the neonates and mother’s height and increase in maternal homocysteine levels. The
data has important implications for pregnancy care in Bangladesh and other similar communities.
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Background
Maternal nutrition plays an important role in placental-
fetal growth and development. Maternal undernutrition
during pregnancy results in intrauterine growth restric-
tion (IUGR) which is associated with increased perinatal
morbidity and mortality. These children have an in-
creased risk for development of metabolic syndrome in
adult life [1, 2].
Evidence shows that the animal embryo comprises two
group of cells in the early embryonic stage. The inner cell
mass which develops as the fetus and the outer cell mass
become the placenta. These developmental process is in-
fluenced by nutrition and hormones [3, 4]. Maternal un-
dernutrition at the time of conception have shown fewer
cells in the inner cell mass in experimental animal studies,
which is associated with reduced birth weight and postna-
tal growth, altered organ/body weight ratios and the devel-
opment of chronic diseases as type 2 diabetes (T2DM),
hypertension (HTN), coronary artery disease (CAD) etc.
[5] Evidence has also suggested that disturbances during
critical periods of fetal development alter the structure or
function of distinct cells, organ systems or homoeostatic
pathways. Therefore, the subjects will have an increased
risk of developing cardiovascular disease and T2DM in
later life [6]. Studies in different time points have found
the association between maternal malnutrition in early
pregnancy and the occurrence of CAD in the offspring.
They have shown that exposure to malnutrition, especially
in late gestation, is linked to impaired glucose tolerance,
while exposure in early gestation is linked to atherogenic
lipid disorders and obesity [7–9].
Low birth weight (LBW) is considered an indicator of
undernutrition in utero. Epidemiological studies have
shown that it is associated with a wide range of adverse
outcomes in later life, including shorter stature, lower
cognitive performance, increased risk factors for later
chronic non-communicable disease including, T2DM,
HTN, CAD, chronic lung and kidney disease [10].
Even though, the obesity level is rising across the
globe, yet more than 20 million infants (15.5% of all
births) are born each year at LBW (< 2.5 kg). LBW re-
mains a problem focused in developing countries, and
half of all LBW babies are born in South and central
Asia [11]. Although fetal growth and birth weight are
known to be influenced by genetic factors, it is influ-
enced most significantly by mothers’ health and nutri-
tional status before and during pregnancy [12]. In
economical transitioning countries, rapid changes in life-
style and nutrition supply within a short time can create
a “mismatch”. A study has shown that adults who had a
coronary event had been small at birth and thin at
2 years of age and thereafter put on weight rapidly. This
type of growth pattern is also related to insulin resist-
ance in later life [13].
Data from Bangladesh in this issue is still scarce. As
dietary patterns vary from country to country, especially
regarding vegetarian and non-vegetarian components in
Bangladesh and its neighboring country Indi. Data from
India may not be directly applicable to people living in
Bangladesh [14].
The purpose of the exploratory study was to examine
the relationship between maternal nutritional status as
assessed by body mass index (BMI) in early pregnancy
and its impact on pregnancy outcomes and neonatal
birth weight. In addition, we examined the relationship
between neonatal birth weight with neonatal metabolic
and micronutrients characteristics.
Methods
Study design and population
This is one of several sub studies of a prospective multi-
center EU FP7 project GIFTS (Genomic and lifestyle
predictors of fetal outcome relevant to diabetes and
obesity and their relevance to prevention strategies in
South Asian peoples) project conducted from April 2011
and June 2012 in Dhaka, Bangladesh. Other GIFTS stud-
ies included analysis of other populations in Pakistan
[15] and Bangladeshi’s in the UK, a micronutrient inter-
vention study in pregnancy in Dhaka (ISRCTN Number:
83599025), genomic predictors of birthweight and gesta-
tional diabetes (GDM) in South Asian populations, ana-
lysis of body composition in Bangladeshi children aged
2–4 in whose mothers were exposed to a community
mobilization program [16], studies in GDM [17–19] and
social and cultural influences of South Asian women
during pregnancy [20].
Study participants were recruited from five areas
(Azimpur, Lalbag, Hazaribag, Kamrangirchar and Kera-
niganj) in the Dhaka city, Bangladesh through the
monthly household visit by Government Family Welfare
Visitors (FWV). These areas are from both urban and
semi-urban areas. During these visits, pregnant women
were identified by a history of a missed menstrual cycle.
Upon confirmation of pregnancy by urine pregnancy test
women were invited to visit the Maternal and Child
Health Training Institute (MCHTI), a tertiary Govern-
ment hospital for antenatal care and registration.
A given error margin (α) of 5% with 95% confidence
from a population of 100,000 and with a prevalence of
undernutrition 30% [21], the required sample size is 322
(two-sided test).
Pregnant women were recruited in first trimester of
their pregnancy (≤14-week gestation). Women who were
primigravida, singleton, conceiving without treatment of
fertility and were willing to participate in the study were
included after written consent (n = 498). Women who
had a history of T2DM, or history of GDM or pregnancy
induced HTN were excluded from this study.
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Date of last menstrual period and ultra-sonographic
examination was performed at the time of recruitment
to register the duration of gestation. Ultra-sonographic
estimation was used as the criterion in case of disparity.
All records from each participant were kept during the
study period (1st visit in first trimester at the time of
registration (between 6 and 14 weeks, n = 498), 2nd visit
between 24 and 28 week of gestation (n = 327) and 3rd
visit at delivery (n = 138). Figure 1 is the study flow dia-
gram detailing the dropouts at each stage of the process.
Each study visit was performed after an overnight fast of
8–12 h.
GDM was diagnosed following a slight modification of
International Association of Diabetes and Pregnancy
Study Group (IADPSG) criteria in the 2nd trimester
(24–28 weeks of gestation). Diagnosis was made by fast-
ing and 2 hours after ingesting 75 g glucose. This was
done to avoid high dropout rate because of 3 blood mea-
sures in pregnancy. GDM was defined as a fasting
plasma glucose (FPG) ≥5.1 mmol/L or plasma glucose
≥8.5 mmol/L 2 hours after ingesting 75 g glucose (2hPG)
[15]. Diabetes in pregnancy was defined as a FPG ≥7.0
mmol/L or 2hPG ≥11.1 mmol/L [22]. Women diagnosed
with GDM and diabetes in pregnancy in visit 2 were not
followed-up to birth as they gave birth in Bangladesh In-
stitute of Research and Rehabilitation in Diabetes, Endo-
crine and Metabolic Disorders (BIRDEM 2), a specialist
Hospital of Diabetic Association of Bangladesh.
Maternal data collection
Data were collected using questionnaire, physical examin-
ation and laboratory investigations. Four trained personnel
were involved in data collection. A structured pre-
formulated questionnaire was used to collect information
on age, place of residence, education, type of occupation,
socio-economic status (assessed by total family monthly
expenditure), family history of chronic diseases including
T2DM, HTN, CAD, and stroke, history of participants’
past illness or any chronic disease, history of addiction,
physical activity level, nutritional status, and pregnancy-
related history from the mother at the baseline visit. Ma-
ternal anthropometry including height, weight, waist, hip
and mid upper arm circumference (MUAC) were mea-
sured (using standardized measurement protocols) at the
Fig. 1 Study flow diagram
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time of registration and repeated at the second visit be-
tween 24 and 28 weeks’ gestation. BMI was calculated as
weight divided by height squared (kg/m2). Waist circum-
ference was measured by placing a plastic tape at the mid-
point between the lower rib margin and the iliac crest.
Similarly, hip was measured by taking the extreme end
posteriorly and the symphysis pubis anteriorly. Mid arm
circumference (MAC) of the left upper arm, measured at
the mid-point between the tip of the shoulder and the tip
of the elbow. In addition, blood pressure was measured in
right hand in sitting position. Prior to the measurement,
10-min rest was assured and using standard cuffs fitted
with sphygmomanometer minimized variation in meas-
urement. Maternal food and nutrient intake were assessed
at each trimester through Food Frequency Questionnaires
(FFQs). The FFQ used in this study had a food list of 135
items. The FFQ consisted of frequency categories (daily,
weekly and monthly). Local household utensils including
glasses, spoons, cups and plates were used for estimating
the amount of foods and beverages consumed by the re-
spondents. These local utensils acted as visual aids to in-
crease the accuracy of portion size estimations. Food
Photo Manual was used, which converts food items of dif-
ferent sizes and composition to gram equivalents. Physical
activity levels of participants at work, at home and during
leisure time (minutes/day) was recorded following a struc-
tured questionnaire used in Bangladesh previously [23].
Maternal blood sample collection and storage
Blood samples were collected for hemoglobin, lipid pro-
file, circulating serum folate, ferritin, homocysteine, vita-
min D (25-Hydroxyvitamin D), and vitamin B12 at 1st
visits and glucose (Fasting and 2-h after 75 g oral glu-
cose), insulin and leptin at both visits (1st and 2nd).
Serum samples were used for the estimation of serum
glucose, lipid profile, insulin, leptin, vitamin D, vitamin
B12, folate, ferritin, homocysteine and whole blood used
for DNA.
Serum glucose was measured by glucose oxidase (Ran-
dox, Laboratories Ltd., UK), serum triglyceride (Tg) by
GPO-PAP method (Randox Laboratories Ltd., UK),
serum cholesterol (Chol) by enzymatic endpoint method
(CHOD-PAP- Randox Laboratories Ltd., UK) and serum
high density lipoprotein cholesterol (HDL-C) by differ-
ential precipitation, enzymatic colorimetric test (Linear
Chemicals, Spain), and low density lipoprotein choles-
terol (LDL-C) was estimated by Friedewald’s formula.
All serum glucose and lipid profile were measured by
using biochemistry auto analyzer (HITACHI 704 Japan),
serum insulin, leptin, vitamin D were measured using
ELISA kits (DRG Instruments GmbH, Germany). Serum
folate, ferritin and vitamin B12 were measured using
chemiluminescence immunoassay (Immulite-1000 / Sie-
mens, USA). Serum total homocysteine was measured
using Microparticle Enzyme Immunoassay (Abbott
AxSYM/ produced by Axis-Shield, Oslo, Norway).
Serum was not allowed to be thawed until the assay is
performed at the Reference Laboratory in Bangladesh
University of Health Sciences (BUHS), Dhaka,
Bangladesh. Homeostasis model assessment of insulin
resistance (HOMA-IR) was calculated using the method
of Matthews et al [24] Intra assay and inter assay coeffi-
cient of variations for the measurement of insulin (5.5
and 4.9), B12 (3.1 and 3.74); folate (4.8 and 6.42), homo-
cysteine (3.75 and 1.10) and Vit D (1.7 and 5) were in
acceptable ranges.
Newborn data collection
Newborn characteristics including sex and gestational
age at birth were recorded at the time of delivery (n =
138). Trained midwives examined all newborns within
24 h of birth. Newborn outcomes of interest included
anthropometric characteristics (length, birth weight,
head circumference, and mid-upper arm circumference
(MUAC)). Newborns’ weight was measured with a
digital scale (Model EN-20. MEA/CTN, China) and
length was measured using a locally manufactured
wooden length board. Head and mid upper arm were
measured using a non-stretchable tape.
Umbilical venous cord blood samples of newborns
were collected immediately following birth and analyzed
for newborn’s serum glucose, insulin, lipids, vitamin D,
vitamin B12, serum ferritin, serum folate, homocysteine
and leptin. Methods and storage for the analysis of cord
blood were same as used for the analysis of maternal
blood.
Statistical analysis
Descriptive statistics in the form of frequencies (n) and
percentages (%) were used to describe the maternal BMI
at 6–14 weeks of pregnancy, which we categorized into
underweight (BMI < 18.5 kg/m2), normal weight (BM
18.5–22.9 kg/m2) and overweight (BMI ≥23 kg/m2) [25].
Similar descriptive statistics were applied to neonatal
birth weights, which we categorized as low (< 2500 g)
and normal weight (≥2500 g) [26]. We used Analysis of
variance (ANOVA) to compare differences of means be-
tween mothers with different maternal nutrition status
and Independent T-test to compare differences in neo-
nates’ birth weights. Pairwise comparisons between the
groups were performed and corrected for multiple test-
ing using Tukey’s HSD. Further, we have used the me-
dians with interquartile range and other related non-
parametric tests including Dunn test and Kruskal-Wallis
test for skewed variables. Chi-square test was used to
test for association between categorical variables. Both
simple and multiple linear regression analyses were done
for prediction of neonatal birth weight by selected
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maternal and neonatal parameters. The modeling
process proceeded in two steps; first simple generalized
linear regression models were fitted to the data in order
to find independent variables with P < 0.20. In the sec-
ond phase, the variables with P < 0.20 and the variables
with P < 0.05 were then used to fit separate multiple gen-
eralized linear regression models. We also checked the
correlation between different variables before starting
multiple generalized linear regression models. Maternal
BMI, LDL-C and HOMA-IR were not included due to
their high correlation with maternal weight (r = 0.91, p <
0.001), total cholesterol (r = 0.80, p < 0.001) and insulin
(r = 0.98, p < 0.001) respectively. At each stage of the
model development, the Akaike Information Criteria
(AIC) was used to check if the inclusion of a variable or
variables improved the model fit [27]. The model with
the smallest AIC value was considered as a better fit. All
analyses were done using Stata SE 14 and IBM SPSS 24
and the significance level was two sided and set at α = 0.05.
Results
Table 1 showed the baseline characteristics of the preg-
nant women based on their BMI measured at their first
visit at 10.1 ± 2.2 weeks gestation. Among the 498
women, 154 (30.9%) were underweight, 241 (48.4%) had
normal weight and 103 (20.7%) were overweight. The
mean age of the women at baseline were 20 ± 2.6 years.
As expected, all the anthropometric indices (including
weight, BMI, waist, waist-hip ratio, and MUAC), systolic
and diastolic blood pressure were significantly lower in
underweight women. Underweight mothers (compared
with normal weight and overweight counterparts) con-
sumed lower fat, whilst ingesting similar levels of carbo-
hydrates and protein; furthermore, they were more
physically active.
Table 2 showed the baseline biochemical parameters of
the pregnant women based on their BMI. Significantly
lower levels of fasting plasma glucose, 2 h plasma glucose
and triglyceride at baseline were observed among under-
weight compared to overweight mothers (p < 0.05). In
addition, insulin, HOMA-IR, cholesterol, LDL-C and leptin
levels were significantly lower in underweight women than
normal weight and overweight women. No significant dif-
ference was observed in vitamin D, vitamin B12, homocyst-
eine, folate and ferritin levels between three groups. The
prevalence of anemia (Hb, < 11 g/dl), vitamin D deficiency
(< 30 nmol/l), vitamin B12 deficiency (< 200 pg/ml), high
homocysteine level (> 15 μmol/l), folate deficiency (< 3 ng/
ml) and iron deficiency (ferritin < 13 ng/ml) were 19.5, 46.4,
15.1, 1.2, 0.4, and 12.7% respectively. Anemia was signifi-
cantly higher in underweight women than in women with
normal weight (27.3 vs 15.4%, p = 0.004). GDM was found
in 18.4% women (58 out of 315 at 24–28weeks). The
prevalence of GDM was significantly higher in overweight
Table 1 Baseline characteristics of pregnant women based on their BMI (kg/m2)
Variables Overall Underweight
(BMI < 18.5)
Normal weight
(BMI 18.5- < 23)
Overweight
(BMI ≥23)
Number, % 498 154 (30.9) 241 (48.4) 103 (20.7)
Age (years) 20.0 (2.6) 19.4 (2.0) 19.7 (2.4) 21.5 (3.4) *†
Gestational age (weeks) 10.1 (2.2) 10.2 (2.2) 10.1 (2.3) 9.9 (2.3)
High SES (> 10,000 BDT), % 160 (32.1) 48 (31.2) 81 (33.6) 31 (30.1)
Weight (Kg) 46.1 (8.5) 38.5 (3.3) 46.0 (4.6) * 57.8 (7.7) *†
Height (cm) 149.7 (5.4) 149.7 (5.3) 149.7 (5.5) 149.6 (5.5)
BMI (kg/m2) 20.6 (3.4) 17.2 (0.99) 20.5 (1.2) * 25.8 (2.9) *†
Waist (cm) 76.5 (9.2) 68.8 (5.0) 76.5 (5.9) * 88.1 (8.4) *†
Hip (cm) 90.5 (7.9) 83.4 (4.9) 90.7 (4.2) * 100.8 (6.7) *†
WHR 0.85 (0.13) 0.83 (0.07) 0.84 (0.05) 0.90 (0.25) *†
MUAC (cm) 23.8 (2.9) 21.3 (1.4) 24.0 (1.8) * 27.2 (2.9) *†
Systolic BP (mmHg) 92.8 (9.3) 90.2 (8.5) 92.9 (9.0) * 96.4 (10.3) *†
Diastolic BP (mmHg) 63.2 (7.2) 61.4 (6.0) 62.7 (6.9) 67.0 (7.9) *†
Physical inactivity, % 35 (7.0) 3 (1.9) 21 (8.7) * 11 (10.7) *
Energy (Kcal/day) 1489.7 (175.9) 1473.2 (175.6) 1487.2 (173.3) 1520.9 (180.0)
Carbohydrate (gm) 215.0 (35.1) 213.7 (34.5) 214.6 (34.0) 217.6 (38.7)
Protein (gm) 52.3 (13.8) 52.8 (13.6) 51.8 (13.8) 53.0 (14.3)
Fat (gm) 45.8 (9.4) 44.4 (9.4) 46.0 (9.2) 47.8 (8.7) *
Data are presented as mean (SD) or number (%)
*p-value < 0.05 compared with underweight; †p-value < 0.05 compared with normal. Abbreviation: BMI body mass index, SES socio-economic condition, BDT
Bangladeshi Taka (1 UDS = 80 BDT), WHR waist-hip ratio, MUAC mid upper arm circumference, BP blood pressure
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women (28.1%) than underweight (16.7%) and normal
weight women (16.0%: p < 0.05). Only three women (0.95%)
were diagnosed with diabetes in pregnancy.
As seen in Fig. 138 of 498 mothers were followed-up
until the birth of their child. Those mothers lost to fol-
low up differed at their first visit (14–18 weeks) in that
they had a lower weight (47.0 vs 45.2 kg; p < 0.01), re-
duced height (151 vs 149 cm; p < 001), increased 2 h glu-
cose (6.2 vs 6.8 mmol/l; p < 001) and increased vitamin
D levels (31 vs 35.3 pg/ml; p = 0.01).
Table 3 showed the demographic and biochemical char-
acteristics of neonates by birth weight category. Among
the 138 neonates, 16 (11.6%) had LBW (< 2500 g) and only
8 (5.8%) were preterm (< 37 weeks). Mean weight (grams),
length (cm), weight for length (kg/m2), head circumfer-
ence (cm), MUAC (cm) and ponderal index was 2814 ±
404, 45.9 ± 2.7, 13.4 ± 1.7, 33.1 ± 1.4, 9.8 ± 0.8 and 2.9 ±
0.5, respectively. LBW babies had significantly lower
length, weight for height, head circumference, MUAC and
ponderal index.
No significant difference was observed for any of the
following parameters (blood glucose, insulin, HOMA-IR,
glucose to insulin ratio, cholesterol, triglyceride, HDL-C,
LDL-C, vitamin D, vitamin B12, folate, ferritin, homo-
cysteine and leptin birth weight levels) in LBW babies
compared to normal weight infants.
Table 4 showed the anthropometric and laboratory pa-
rameters of neonates categorized by their mothers’ BMI.
No significant difference for anthropometric indices (birth
weight, birth length, head circumference, and MUAC) was
observed among neonates born to underweight mothers
at inclusion than normal weight mothers. Significant
higher cord blood glucose (4.3 vs 3.7 mmol/L), blood chol-
esterol (67.0 vs 60.5mg/dl), HDL-C (25.0 vs 21.5mg/dl)
and lower vitamin B12 (372.0 vs 514.5 pg/ml) values were
observed in neonates born to underweight mothers than
overweight/obese mothers.
Table 5 showed the associations between neonatal birth
weight and maternal characteristics in early pregnancy.
Maternal height and weight at baseline were positively
Table 2 Baseline biochemical parameters of pregnant women based on their BMI (kg/m2)
Variables Overall Underweight
(BMI < 18.5)
Normal weight
(BMI 18.5- < 23)
Overweight
(BMI ≥23)
Number, % 498 154 (30.9) 241 (48.4) 103 (20.7)
Hb (g/dl) 12.1 (11.3, 12.9) 12.1 (10.9, 12.9) 12.1 (11.3, 12.9) 12.1 (11.3, 13.3)
Anemia (Hb < 11 g/dl), % 97 (19.5) 42 (27.3) 37 (15.4) * 18 (17.5)
FPG (mmol/l) 4.7 (4.5, 5.0) 4.7 (4.5, 4.9) 4.7 (4.5, 5.1) 4.8 (4.6, 5.2) *†
2hPG (mmol/l) 6.2 (5.3, 7.0) 6.3 (5.4, 7.6) 6.4 (5.4, 7.3) 7.0 (6.1, 8.0) *†
GDM, % a 58 (18.4) 16 (16.7) 26 (16.0) 16 (28.1) *†
Insulin (μIU/ml) 7.6 (5.4, 10.3) 7.1 (5.0, 8.9) 7.6 (5.4, 10.0) * 9.7 (7.5, 15.2) *†
HOMA-IR 1.6 (1.1, 2.2) 1.5 (1.0, 1.9) 1.6 (1.1, 2.2) * 2.1 (1.6, 3.2) *†
Cholesterol (mg/dl) 163.0 (150.0, 180.0) 156.0 (150.0, 170.3) 162.0 (150.0, 181.0) * 172.0 (156, 200) *†
Triglycerides (mg/dl) 102.5 (80.0, 132.8) 91.5 (75.0, 124.5) 100.5 (78.0, 136.8) 122.0 (92, 147.0) *†
HDL-C (mg/dl) 43.0 (38.0, 48.8) 43.0 (38.8, 49.0) 42.0 (37.0, 52.0) 42.0 (36.0, 48.0)
LDL-C (mg/dl) 97.0 (88.0, 112.0) 94.0 (84.8, 104.0) 99.0 (90.0, 114.0) * 104.0 (92.0, 125.0) *
Vitamin D (nmol/l) 30.2 (18.6, 41.8) 30.5 (18.1, 42.5) 31.2 (17.7, 43.8) 32.8 (20.3, 47.2)
Deficiency (< 30 nmol/l), % 231 (46.4) 75 (48.7) 112 (46.5) 44 (42.7)
Vitamin B12 (pg/ml) 296.5 (221.5, 389.8) 295.0 (222.3, 432.8) 304.0 (226.3, 406.5) 295.0 (251.3, 370.5)
Deficiency (< 200 pg/ml), % 76 (15.1) 26 (16.9) 40 (16.6) 10 (9.7)
Homocysteine (μmol/l) 7.0 (5.9, 8.8) 7.0 (5.7, 8.8) 7.0 (5.7, 8.6) 6.8 (5.7, 8.1)
High (> 15 μmol/l), % 6 (1.2) 3 (1.9) 3 (1.3) –
Folate (ng/ml) 10.5 (7.7, 18.5) 11.3 (7.6, 18.7) 10.3 (7.6, 20.1) 9.8 (7.6, 14.3)
Deficiency (< 3 ng/ml), % 2 (0.4) – – 2 (1.9)
Ferritin (ng/ml) 45.6 (23.3, 75.2) 45.4 (25.9, 84.2) 45.9 (22.6, 72.7) 49.0 (28.7, 75.6)
Deficiency (< 13 ng/ml), % 63 (12.7) 16 (10.4) 31 (12.9) 16 (15.7)
Leptin (ng/ml) 7.3 (4.6, 12.2) 4.6 (3.4, 6.6) 7.3 (5.4, 11.1) * 16.2 (11.4, 23.2) *†
Data are presented as median (interquartile range) or number (%). Biochemical assays were all measured in serum. a from 2nd visit
*p-value < 0.05 compared with underweight; †p-value < 0.05 compared with normal. Abbreviation: BMI body mass index, FPG fasting plasma glucose, 2hPG 2 h
plasma glucose, GDM gestational diabetes, HOMA-IR homeostasis model assessment of insulin resistance, HDL-C high density lipoprotein cholesterol, LDL-C low
density lipoprotein cholesterol
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associated with neonatal birth weight in the univariate
analysis. In the adjusted analysis (model 2), maternal
height was positively associated with neonatal birth weight
(p = 0.02) while homocysteine was negatively associated
with neonatal birth weight (p = 0.02). Model 2 showed that
a unit increase in homocysteine was associated with a
33.26 g decrease in mean birth weight (p = 0.02).
The associations between neonatal birth weight and
neonatal cardiometabolic and micronutrients character-
istics were presented in Table 6. The univariate analysis
showed that folate was positively associated with neo-
natal birth weight while triglyceride was negatively asso-
ciated with neonatal birth weight. In the adjusted
analysis (model 2), a unit increase in triglycerides was
associated with a decrease in birth weight of 2.81 g (p =
0.02). However, a unit increase in folate significantly in-
crease birth weight by 5.26 g (p = 0.03).
Figure 2 illustrated maternal (including height and
homocysteine) and neonatal (including cord triglyceride
and folate) factors that were significantly associated with
neonatal birth weight.
Discussion
Our data reports the maternal characteristics and nutri-
tional status in early pregnancy (6–14 weeks) and its im-
pact on neonatal birth weight. High prevalence of both
underweight (< 18.5 kg/m2) and overweight (BMI ≥23
kg/m2) were observed in our study. Our findings are in
line with 2007 Bangladesh Demographic and Health Sur-
vey (BDHS) [28]. As our assessment occurred in early
pregnancy, the observed weight gain is likely related to
the pre-pregnancy status. Our findings are consistent
with other rural and urban studies in Bangladesh who
also identified similar prevalence of women with low
Table 3 Demographic and biochemical characteristics of neonates at birth, categorized by birth weight
Variables Overall Low birth weight
(weight < 2500 g)
Normal birth weight
(weight≥ 2500 g)
Number, % a 138 16 (11.6) 122 (88.4)
Sex (male), n, % a 74 (53.6) 5 (31.3) 69 (56.6)
Preterm (< 37 weeks), n, % a 8 (5.8) 3 (18.8) 5 (4.1) *
Delivery (caesarian section), n, % a 90 (65.2) 8 (50.0) 82 (67.2)
Gestational age at delivery (weeks) b 40.2 (1.6) 40.4 (2.6) 40.2 (1.4)
Weight (gram) b 2814 (404) 2146 (166) 2899 (342) *
Length (cm) b 45.9 (2.7) 43.6 (2.8) 46.3 (2.5) *
Weight for height (kg/m2) b 13.4 (1.7) 11.3 (1.0) 13.6 (1.6) *
Head circumference (cm) b 33.1 (1.4) 31.4 (1.4) 33.3 (1.3) *
MUAC (cm) b 9.8 (0.8) 9.1 (0.7) 9.9 (0.8) *
Ponderal index b 2.9 (0.5) 2.6 (0.4) 3.0 (0.5) *
Biochemical parameters
Blood glucose (mmol/l) c 3.8 (3.3, 5.1) 4.3 (3.2, 5.1) 3.8 (3.3, 5.1)
Insulin (μIU/ml) c 6.5 (5.0, 11.5) 5.6 (3.5, 15.1) 6.6 (4.6, 11.4)
HOMA-IR c 1.18 (0.74, 2.30) 1.23 (0.56, 2.85) 1.18 (0.74, 2.27)
Glucose to insulin ratio c 10.6 (7.1, 15.6) 10.9 (6.1, 17.9) 10.5 (7.4, 15.2)
Cholesterol (mg/dl) c 66.0 (56.0, 78.0) 64.0 (47.0, 77.0) 66.0 (56.3, 78.8)
Triglycerides (mg/dl) c 35.0 (26.0, 50.0) 48.0 (28.0, 76.0) 34.5 (25.3, 48.0)
HDL-C (mg/dl) c 23.0 (19.0, 30.0) 19.0 (16.0, 29.0) 24.0 (20.0, 30.0)
LDL-C (mg/dl) c 33.0 (25.0, 41.0) 32.0 (17.0, 39.0) 33.0 (25.0, 41.0)
Vitamin D (nmol/l) c 33.9 (28.3, 45.2) 31.2 (27.8, 45.3) 34.5 (28.7, 45.2)
Vitamin B12 (pg/ml) c 417.0 (329.3, 640.3) 414.0 (258.5, 669.0) 421.0 (340.0, 629.5)
Homocysteine (μmol/l) c 5.0 (4.0, 6.4) 5.5 (4.5, 6.9) 5.0 (4.0, 6.3)
Folate (ng/ml) c 16.8 (14.2, 21.8) 13.7 (12.3, 20.3) 16.8 (14.4, 22.2)
Ferritin (ng/ml) c 119.0 (58.8, 197.0) 112.0 (61.1, 155.0) 127.0 (59.3, 200.0)
Leptin (ng/ml) c 5.1 (3.0, 7.8) 5.3 (2.9, 7.1) 5.1 (3.0, 8.1)
Data are presented as a number (%) or b mean (SD) or c median (interquartile range) where appropriate. Biochemical assays were all measured in serum. *p-value
< 0.05 compared with LBW. Abbreviation: LBW low birth weight, MUAC mid upper arm circumference, HOMA-IR homeostasis model assessment of insulin
resistance, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol
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BMI in early pregnancy, but the rate of overweight/obes-
ity was lower. This is likely to be a consequence of ap-
plying the newer WHO defined cutoff levels for BMI in
South Asian populations [29–31].
In our study, we assessed the level of micronutrient
status in early pregnancy (gestational age 10.1 ± 2.2
week), therefore the chances of confounding effect of he-
modilution which is common in late pregnancy was un-
likely. Our data showed a high prevalence of vitamin D
deficiency and insufficiency in pregnant women in early
pregnancy. Studies in Pakistan with identical definition
for vitamin D deficiency with similar inclusion criteria
had shown similar results [15, 32]. Similar findings were
also observed in other studies conducted in Bangladesh
[33] and India [34].
Limited dietary sources, dark skin pigmentation, and reli-
gious or cultural practices that limit skin exposure to sun-
light may prevent endogenous production of vitamin D, as
illustrated by El-Sonbaty and Abdul-Ghaffar et al. [35] and
Guzel et al. [36] may in part explain the higher occurrence
of hypovitaminosis in a population with abundant exposure
to sunlight year-round. The average sun exposure in Dhaka
was 12 h and above during the months of recruitment
(April – September) and therefore it is less likely that vita-
min D levels may have been impacted by sunlight exposure.
Most importantly daily dietary intake of vitamin D was low
(normal 15 μgm vs 4.34 μgm) in our study population. This
may suggest that dietary intervention with vitamin D rich
foods may be an appropriate strategy to address the issue.
Increasing evidence suggest that vitamin B12 defi-
ciency is highly prevalent in women of reproductive age,
particularly amongst populations with limited intake of
animal source foods [32, 37]. Evidence also suggests that
vitamin B12 concentration gradually decline throughout
gestation, therefore, it is challenging to assess the preva-
lence of deficiency in pregnant women. Studies have
shown that based on gestational week, prevalence of
vitamin B12 deficiency may vary from 5% (< 28 days ges-
tation) to 72% (immediately prior to delivery) worldwide
[38]. The JiVitA study in rural north-western Bangladesh
found a prevalence of 20% deficiency in early pregnancy
[39]. Another urban study conducted in similar settings
of present study in Dhaka city found 26% deficiency in
early pregnancy [40]. Our finding is in line with national
micronutrient status survey in Bangladesh [41] and
Amsterdam Born Children and their Development
Table 4 Anthropometric and laboratory parameters of neonates at birth, categorized by maternal BMI (kg/m2)
Underweight
(BMI < 18.5)
Normal weight
(BMI 18.5- < 23)
Overweight
(BMI ≥23)
Total number (n = 138) 38 67 33
Anthropometric indices
Birth weight (gram)a 2700 (400) 2800 (400) 2900 (400)
Birth length (cm) a 45.4 (3.1) 46.3 (2.6) 45.9 (2.3)
Head circumference (cm) a 32.9 (1.3) 33.0 (1.5) 33.4 (2.7)
MUAC (cm) a 9.7 (0.8) 9.8 (0.8) 9.8 (0.9)
Laboratory parameters
Blood glucose (mmol/l) b 4.3 (3.4, 5.2) 3.7 (3.3, 5.1) 3.7 (3.2, 4.2) *
Insulin (μIU/ml) b 6.0 (4.3, 13.5) 7.3 (3.2, 12.1) 6.1 (4.6, 9.4)
HOMA-IR b 1.1 (0.7, 2.7) 1.4 (0.8, 2.6) 1.1 (0.7, 1.5)
Glucose to insulin ratio b 11.5 (8.3, 16.0) 10.0 (6.5, 16.1) 10.3 (7.2, 15.1)
Cholesterol (mg/dl) b 67.0 (58.5, 85.0) 67.5 (56.3, 75.8) 60.5 (50.8, 66.3) *
Triglycerides (mg/dl) b 40.0 (28.5, 48.5) 35.5 (24.0, 52.0) 34.0 (28.0, 53.0)
HDL-C (mg/dl) b 25.0 (20.0, 34.0) 23.0 (19.3, 31.0) 21.5 (17.5, 27.0) *
LDL-C (mg/dl) b 36.0 (25.0, 43.0) 35.5 (26.5, 41.8) 30.0 (24.8, 35.0)
Vitamin D (nmol/l) b 31.7 (27.1, 42.7) 33.6 (28.4, 43.7) 38.2 (31.5, 46.6)
Vitamin B12 (pg/ml) b 372.0 (297.3, 496.8) 424.5 (297.0, 641.5) 514.5 (369.0, 751.0) *†
Homocysteine (μmol/l) b 5.4 (4.6, 7.2) 5.0 (4.0, 6.0) 4.7 (3.6, 6.4)
Folate (ng/ml) b 15.8 (13.2, 24.8) 17.3 (13.8, 22.4) 16.5 (14.5, 18.7)
Ferritin (ng/ml) b 103.8 (61.5, 253.8) 142.5 (64.4, 203.8) 81.6 (43.5, 161.0)
Leptin (ng/ml) b 4.3 (2.7, 8.1) 5.1 (2.9, 8.8) 5.7 (4.0, 7.1)
Data are presented as a mean (SD) or b median (interquartile range)
*p-value < 0.05 compared with underweight; †p-value < 0.05 compared with normal. Abbreviation: BMI body mass index, MUAC mid upper arm circumference,
HOMA-IR homeostasis model assessment of insulin resistance, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol
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(ABCD) study, Netherland [42]. However, our results are
in contrast with Pune, Indian study [37] and Maternal
and Infant Nutrition Interventions in Matlab (MINI-
MAT) trial in Bangladesh where reported B12 status
(46% deficiency) early in their third trimester [31]. One-
third of women in Pune study were vegetarian and they
consumed less protein (44.9 vs 52.3 g) and fat (32.7 vs
45.8 g) than our participated women. However, average
daily dietary intake of vitamin B12 in our study popula-
tion need to be increased as this was observed low (1.62
mcg) compare to recommended daily intake (2.6 mcg)
for Bangladeshi population. Further, Bangladesh diet
contains high level of fish compared to many societies
with non-vegetarian diet.
Regarding iron and folate deficiency, our findings are
consistent with other previous urban study in
Bangladesh [40]. Lower levels of folate deficiency (0.2%)
was also observed in Pune, India study. Further, it was
reported that higher maternal folate concentrations pre-
dict greater adiposity and higher insulin resistance in ne-
onates [43]. Furthermore, universal distribution of folate
and iron to all pregnant mothers in Bangladesh may
have reduced folate deficiency.
The prevalence of GDM in our study was 18.4%. Two
similar studies in India and China with identical defin-
ition for GDM reported 18.5 and 19.9% prevalence re-
spectively [44, 45]. Bangladesh still has high maternal
mortality rate (340/100,000), which is one of the highest
in the world [46]. It is alarming though to observe the
higher occurrence of GDM in women defined as under
or normal weight, considered as low risk. Further inves-
tigation is required to define the disposition of the
phenotype and prognosis particularly at a time when the
upswing of diabetes is threatening the health system in
poor countries.
Like many other developing countries, millions of Ban-
gladeshi children suffer from nutritional deficiencies due
to their mothers’ poor nutritional status prior to and
during pregnancy. Children are often born with LBW.
According to National LBW Survey 2003–2004 reports,
36% babies were born with LBW. The mean birth weight
of infants in Bangladesh is 2632 g and the mean birth
Table 5 Generalized linear regression analysis showing the associations between neonatal birth weight and maternal measures.
Using the Akaike information criteria (AIC), model 2 was selected because it has the smallest AIC value
Maternal variables Univariate (unadjusted) 1Full model (n = 138)
AIC = 2071.32
2Model 2 (n = 138)
AIC = 2053.40
3Model 3 (n = 138)
AIC = 2066.53
β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value
Height (cm) 17.42 (5.82, 29.01) < 0.01 20.32 (5.65, 34.99) 0.01 14.97 (2.51, 27.43) 0.02 13.1 (0.76, 25.42) 0.04
Weight (kg) 11.15 (3.20, 19.09) 0.01 3.80 (−6.84, 14.44) 0.48 6.86 (−1.62, 15.35) 0.11 7.75 (−0.67, 16.16) 0.07
Homocysteine
(μmol/l)
−26.67 (−54.78, 1.44) 0.06 −32.99 (− 62.03, −3.95) 0.03 −33.26 (− 60.21, − 6.31) 0.02
2hPG (mmol/l) 44.93 (− 15.76, 105.62) 0.15 51.54 (− 11.97, 115.06) 0.11 51.31 (−8.00, 110.63) 0.09
Triglycerides
(mg/dl)
−0.93 (−2.21, 0.34) 0.15 −0.96 (−2.48, 0.56) 0.22 −1.09 (− 2.31, 0.14) 0.08
Hemoglobin −24.88 (− 80.13, 30.38) 0.38 −5.75 (−68.68, 57.18) 0.86
FPG (mmol/l) 70.77 (−70.28, 211.82) 0.32 46.92 (−97.80, 191.65) 0.53
Insulin (μIU/ml) 7.38 (−6.76, 21.51) 0.30 11.07 (−4.59, 26.74) 0.17
Cholesterol (mg/dl) −0.43 (−3.30, 2.44) 0.77 −0.94 (− 4.36, 2.48) 0.59
HDL-C (mg/dl) 5.59 (−4.88, 16.06) 0.29 6.01 (−5.43, 17.44) 0.30
Vitamin D (nmol/l) −0.96 (− 5.27, 3.35) 0.66 −0.45 (− 5.01, 4.11) 0.85
Vitamin B12 (pg/ml) 0.10 (−0.40, 0.60) 0.69 −0.07 (− 0.60, 0.46) 0.80
Ferritin (ng/ml) 0.56 (−0.98, 2.11) 0.47 0.45 (−1.15, 2.04) 0.58
Folate (ng/ml) −2.72 (−10.88, 5.43) 0.51 −0.51 (−9.00, 7.97) 0.91
Age (years) 12.69 (−10.50, 35.88) 0.28 −6.08 (−32.70, 20.55) 0.66
Gestational age
in weeks
−11.83 (−55.64, 31.98) 0.60 −24.20 (−70.14, 21.74) 0.30
BMI (kg/m2) 16.28 (−3.01, 35.58) 0.10
LDL-C (mg/dl) −0.27 (−3.29, 2.75) 0.86
HOMA-IR 41.48 (−18.76, 101.72) 0.18
1Model 1 is adjusted for all maternal variables 2Model 2 was fitted by selecting variables with P ≤ 0.2 from the univariate analysis
3Model 3 was fitted by selecting variables with P ≤ 0.05 from the univariate analysis
Abbreviation: 2hPG 2 h plasma glucose, FPG fasting plasma glucose, HDL-C high density lipoprotein cholesterol, BMI body mass index, LDL-C low density
lipoprotein cholesterol, HOMA-IR homeostasis model assessment of insulin resistance
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length is 48.5 cm [47]. In our study, incidence of LBW
and preterm delivery were 11.6 and 5.8% respectively in
our study. Preterm birth rate found higher in LBW ba-
bies. Bangladesh Demographic and Health Survey
(BDHS) 2011 and MINIMAT trail reported 16 and 20%
LBW respectively [41, 31]. They had significantly lower
head circumference but there was no significant differ-
ence in gestation age or with mother’s BMI status in
early pregnancy.
Our results showed that neonates born to underweight
mothers had significantly higher blood glucose, higher
cholesterol, but higher HDL-C, and lower vitamin B12
than neonates born to overweight mothers irrespective
of their birth weight. Mechanisms underlying these asso-
ciations are still poorly understood. However, our find-
ings reflect the possible interaction of environmental
factors and fetal growth and the in-utero glucose and
lipid metabolism. Future long-term longitudinal studies
in different ethnicities would help to explore the under-
lying mechanisms.
Finally, we investigated both maternal and neonatal
nutritional and cardiometabolic factors on newborn
Table 6 Generalized linear regression analysis showing the associations between neonatal birth weight and neonatal
cardiometabolic and micronutrient variables. Using the Akaike information criteria (AIC), model 2 was selected because it has the
smallest AIC value
Neonatal variables Univariate (unadjusted) 1Full Model (n = 138)
AIC = 1903.11
2Model 2 (n = 138)
AIC = 1713.23
3Model 3 (n = 138)
AIC = 1810.955
β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value
Triglyceride (mg/dl) −3.60 (−6.11, −1.08) 0.01 −2.18 (−5.27, 0.91) 0.17 −2.81 (− 5.33, −0.29) 0.03 − 3.25 (− 5.75, − 0.75) 0.01
Folate (ng/ml) 5.15 (0.72, 9.57) 0.02 5.41 (0.23, 10.59) 0.04 5.26 (0.47, 10.05) 0.03 4.77 (0.45, 9.09) 0.03
Blood glucose
(mmol/l)
−41.98 (−88.39, 4.43) 0.08 −29.54 (−97.25, 38.16) 0.39 −38.39 (−90.27, 13.50) 0.15
Glucose insulin
ratio (GIR)
−5.38 (−12.60, 1.84) 0.14 −2.98 (−16.77, 10.81) 0.67 −0.28 (− 8.66, 8.10) 0.95
Homocysteine
(μmol/l)
−27.39 (−59.44, 4.67) 0.09 −21.43 (−55.87, 13.01) 0.22 −18.34 (− 50.38, 13.70) 0.26
Insulin (μIU/ml) 3.04 (−8.85, 14.94) 0.61 −8.32 (−29.48, 12.83) 0.44
Cholesterol (mg/dl) −1.62 (−4.99, 1.74) 0.34 −6.15 (−13.55, 1.25) 0.10
HDL- C (mg/dl) 3.18 (−3.83, 10.19) 0.37 9.91 (−1.52, 21.34) 0.09
LDL-C (mg/dl) 0.06 (−4.92, 5.04) 0.98 8.57 (−0.79, 17.92) 0.07
Vitamin D (nmol/l) 1.10 (−4.41, 6.61) 0.69 1.45 (−4.01, 6.91) 0.60
Vitamin B12 (pg/ml) 0.02 (−0.30, 0.35) 0.89 −0.03 (− 0.38, 0.33) 0.87
Ferritin (ng/ml) 0.06 (−0.62, 0.74) 0.86 −0.06 (− 0.77, 0.65) 0.87
Leptin (ng/ml) 4.81 (−9.24, 18.87) 0.50 −0.75 (−14.71, 13.20) 0.92
Gestational age
in weeks
−11.83 (−55.64, 31.98) 0.60 − 19.19 (−68.13, 29.74) 0.44
1Model 1 is adjusted for all neonatal variables 2Model 2 was fitted by selecting variables with P ≤ 0.2 from the univariate analysis
3Model 3 was fitted by selecting variables with P ≤ 0.05 from the univariate analysis
Abbreviation: HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol
Fig. 2 Maternal and neonatal factors that were significantly associated with neonatal birth weight
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birth weight. In our study, maternal height and weight at
inclusion were positively associated with neonatal birth
weight in univariate analysis. In the adjusted analysis, ma-
ternal height was positively, and homocysteine was nega-
tively associated with neonatal birth weight. A series of
studies investigated the relationship between maternal
height and birth weight showed that shorter maternal
height was associated with reduced fetal growth and low
birth weight [31, 48–51]. They concluded that the primary
reason for this association was undernutrition/malnutri-
tion. Negative association of maternal homocysteine con-
centrations with newborn birth weight is consistent with
studies conducted in India [52, 53] and Norway [54]. We
observed a unit increase in homocysteine was associated
with a 33.3 g decrease in mean birth weight in our study.
Interestingly, a similar finding has also been observed in a
systemic review and meta-analysis conducted by Hogev-
een M et al [55] They reported that a one standard
deviation (SD) increase in maternal homocysteine corre-
sponded to a decrease in birth weight of 31 g. Homocyst-
eine is a well-recognized risk factor for endothelial
dysfunction and cardiovascular disease. Homocysteine
concentrations are influenced by vitamin B status, mainly
by folate and Vit B12. Therefore, vitamin B supplementa-
tion should be introduced to the pregnant women for low-
ering maternal homocysteine level and reducing its wide
range of adverse pregnancy outcomes, including recurrent
early pregnancy loss, preeclampsia, LBW, fetal loss and fu-
ture risk of cardiovascular disease.
Among the neonatal variable, cord folate was posi-
tively, and triglyceride was negatively associated with
birth weight. Literature has shown that folic acid supple-
ment during the last 12 to 16 weeks of pregnancy deliv-
ered heavier babies than those born to mothers receiving
iron alone. Further, it was found that the effect of the
folic acid supplements was more marked on first born
children [ 56].
As in other studies, we have found that lower birth
weight was associated with elevated cord triglyceride
concentrations [57–59]. Reduced lipoprotein lipase
(LPL) activity might be the theoretical explanation for
the inverse correlation between fetal cord triglyceride
and birth weight. It is known that the expression of LPL
is strongly associated with the development of adipose
tissue. LBW infants appear to have impaired utilization
of circulating triglyceride, because of lacking peripheral
adipose tissue [60].
Among the strengths of the study were interviewer
training for interview technique, questionnaires, recall of
the participants, anthropometric measurements, collec-
tion of blood, and its subsequent processing (centrifuga-
tion and storage). Primigravida mothers were recruited
in their 1st trimester to avoid any noise interfering with
the analysis. All the maternal and cord blood parameters
were determined in the same laboratory, should reduce
the chance of error due to different analysis technique.
This study also creates an opportunity for long time
follow-up of study participants and their offspring which
will serve as a relevant data bank for future studies. The
limitations of the present study include a higher number
of dropouts and thereby limited number of neonatal
samples especially those with very low birthweight (n =
16). It should be noted that the exclusion of GDM
mothers in their second visit, political violence during
the study period were the major causes of participants’
dropout. In addition, the local cultural practice in
Bangladesh is that primigravida mothers deliver the child
in their parent’s house; this caused a major undertaking
to trace all the participants. Because of limited project
budget funds and the logistics of cord blood collection
and sample processing, we could not collect samples
from the majority of home deliveries; analysis of the ne-
onates was therefore mainly restricted to hospital deliv-
eries to ensure data integrity. Reassuringly, with respect
to analysis of the neonate data, there is no significant
difference in terms of the nutrition status in those
mothers who were recruited initially (n = 498) and those
who delivered in the hospital (n = 138). At recruitment,
30.9% of the women were categorized as having low
BMI (< 18.5), 48.4% normal BMI (18.5–22.9), and 23.9%
(overweight and obese). The samples from the newborns
were collected from (n = 138) deliveries from the hospi-
tals. Those mothers who delivered were categorized as
low BMI were 27.5%, normal 48.6% and over-weight and
obese were 23.7%. The difference was not statistically
significant (p = 0.43). Therefore, it is less likely that the
results were influenced by the high rate of dropouts.
Even though areas of residence were selected based on
a random sampling procedure but the population were
selected from five areas in and around Dhaka city. The
people in Bangladesh (98–99%) belong to one ethnic
group and have similar body structure. Therefore, results
may be interpreted with caution to the Indian Bengali
population.
However, we could not find any significant differences
in the baseline-data for mothers delivered in the hospital
or home related to BMI, and therefore, it is less likely to
have impacted the results. Home delivery is common in
Bangladesh especially in rural and semi-urban popula-
tion [40]. Micronutrients were assessed only at early ges-
tation in this study, whereas they might also be
important for fetal growth at the later gestational period
[7–9]. This could be another potential limitation of this
study.
Conclusion
Maternal malnutrition including both micro (iron defi-
ciency, vitamin D deficiency, vitamin B12 deficiency,
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high homocysteine level and folate deficiency) and un-
dernutrition as measured by BMI was highly prevalent
in early pregnancy. LBW was associated with lower fol-
ate, elevated cord triglyceride concentrations of the neo-
nates and mother’s height and increase in maternal
homocysteine levels. Neonates born to underweight
mothers exhibited significantly higher blood glucose,
cholesterol, higher HDL-C and lower vitamin B12 irre-
spective of their birth weight although this conclusion
should be tempered by the numbers studied. The results
may call for closer monitoring of pregnant women by
the antenatal clinics. The data has also important impli-
cations for pregnancy care in Bangladesh and other simi-
lar communities.
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